J&J Vision's next generation of customized LASIK treatment, iDESIGN refractive studio gets US FDA approval

10:12 EDT 20 Jun 2018 | PharmaBiz

Johnson & Johnson Vision announced the US Food and Drug Administration (FDA) approval of the iDESIGN refractive studio, making it the only system to use topography─integrated, wavefront─guided technology.

More From BioPortfolio on "J&J Vision's next generation of customized LASIK treatment, iDESIGN refractive studio gets US FDA approval"